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DIABETES MELLITUS









To characterize the pattern of lipid profile abnormalities among Nigerians with type 2 diabetes
mellitus attending the Diabetes clinic of a tertiary referral centre in Nigeria.
Across sectional analysis of 192 diabetic patients consecutively recruited from patients attending the
Diabetes clinic and 52 volunteering non-diabetic and non-hypertensive controls was undertaken. The main
outcome measures were lipid profile and anthropometric indices. Data analysis was done with SPSS version
10. Results were expressed as mean ± SD. Differences between groups were regarded as significant at p < 0.05.
Comparisons of means, test of association were done using independent t-test, chi-square test and bivariate
(Pearson's) correlation analysis.
Eighty-nine percent of the patients had at least one abnormal lipid profile while 64.5% had combined
dyslipidaemia. Reduced HDL-C and raised TG constituted the most (88.0%) and least (25.0%) prevalent
abnormalities respectively. Significant difference in the mean values of HDL-C and LDL-C was observed
between the patients and controls.
Dyslipidaemia is common among patients with type 2 diabetes mellitus in Nigeria with majority
of the patients having a combined dyslipidaemia. There is therefore the need to pay great attention to the lipid
parameters in Nigerians with type 2 diabetes mellitus.
TG Triglycerides, TC total cholesterol, LDL-C Low Density Lipoprotein Cholesterol,
HDL-C High Density Lipoprotein Cholesterol, WC Waist circumference, HC Hip circumference, BMI
Body mass index, WHR Waist-hip ratio.
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INTRODUCTION
Type 2 diabetes mellitus is commonly associated
with a cluster of abnormal lipid profiles which are
known to be atherogenic. Dyslipidaemia is a well
recognized and modifiable risk factor for
cardiovascular diseases which is currently a leading
cause of morbidity and mortality world wide in both
developed and developing regions including Africa.
Among other disorders, it is one of the defining
factors or criteria for the metabolic syndrome and it
is associated with obesity most especially the
visceral type; also a defining criterion for metabolic
syndrome. Currently, environmental adaptations and
changes in lifestyle are known to be responsible for
the rise in the prevalence of obesity being witnessed
in most parts of the world. These changes are related
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to increasing sedentary lifestyle and physical
inactivity ('westernisation').Developing nations are
currently witnessing rapid urbanisat ion,
industrialisation as well as increased economic
capabilities; which has the propensity of leading to
abnormal weight gain and development of various
complication of obesity. Obesity has been linked with
lipid abnormalities in Africans. In Nigeria,
hypertension and diabetes mellitus were noted to
occur in 10-15% and 2-4% of the population
respectively. Diabetes and hypertension however are
known to frequently co-exist though they are
independent risk factors for dyslipidaemia. The
frequency of hypertension among diabetic patients in
Nigeria is between 20 40%.
Several combinations of abnormal lipid parameters
have been noted , but the combination of raised





small dense low density lipoprotein particles
characterizes diabetic dyslipidaemia. Each of these
abnormalit ies is however, independently
atherogenic. The very high risk of atherogenicity
associated with the small dense LDL particles has
resulted in emphasis on ensuring that LDL-C is
within the therapeutic goal in management of
dyslipidaemia in diabetic patients. In China, typical
diabetic dyslipidaemia was reported by Ko GT et al.
Other patterns such as elevated TG and low HDL-C
as well as significant proportion of quantitative
dyslipidaemia especially with the Total--and LDL-
cholesterols have been observed in Kuwait and
Nairobi respectively.
In this report, we analysed the pattern of
dyslipidaemia among adult diabetic patients
attending the out-patient diabetes clinic of a tertiary
hospital in Nigeria.
A cross-sectional survey of 192 type 2 diabetic
patients (83 males, 109 females) in attendance at the
diabetic clinic of the Lagos University Teaching
Hospital (LUTH) and 52 non-diabetic controls was
undertaken. LUTH is one of the premier tertiary
hospitals in Nigeria. It is located in lagos, Western
Nigeria, the former capital of Nigeria and a well
known commercial nerve centre in the country.
Consenting adult type 2 diabetic patients (diabetic
patients who were being managed on oral
hypoglycaemic agents or insulin as a result of
secondary failure of oral hypoglycaemic agents)
were consecutively recruited. Patients who failed to
give informed consent or who were on lipid lowering
drugs were excluded. Fifty-two non-diabetic and
nonhypertensive controls were also recruited for the
study.
Diagnosis of diabetes mellitus in new patients was
based on the diagnostic guidelines according to
American diabetes association (ADA) while
dyslipidaemia was defined using the National
Cholesterol Education Programme (NCEP-ATP III)
criteria as follows: TC > 5.2 mmol/l, LDL-C > 3.4
mmol/l, HDL-C < 1.03 mmol/l for males, < 1.3
mmol/l for females and TG > 2.3 mmol/l .
Hypertension was considered present if a patient had
been a known hypertensive and / or is on
antihypertensive medication(s) or have taken such
medications in the past having been prescribed by a
doctor.
Blood pressure readings were based on the JNC VI
classification and guidelines. Waist and hip
circumferences were determined using a flexible
tape with subjects putting on light clothing only and









Waist circumference was measured at the midpoint
between the costal angles and the iliac crests while
hip circumference was measured at the level of the
greater trochanters.
Fasting venous blood sample drawn
from the subjects after adequate disinfection of the
skin over the venepuncture site, was separated to
obtain plasma which was then stored frozen until
analysed. Samples were analysed within forty-eight
hours after collection. Total cholesterol was
determined using the ferric perchlorate method
while HDL-C was determined after precipitation of
LDL-C with phosphotungstate and magnesium.
LDL-C was calculated from Friedwald's formula:
LDL-C =TC HDL-C (TG/5)
TG was measured using the colourimetric enzymatic
method
Assessment of glycaemic and blood pressure control
was based on average of the readings from
consecutive visits which included last visit before
recruitment, day of recruitment and the next visit after
recruitment.
Statistical analysis;
Data analysis was done using SPSS v 10. Results
were expressed as mean ± SD where necessary.
Comparisons of means, test of association were done
using independent t-test, and chi-square test.
Bivariate correlation was performed using Pearson's
correlation coefficient. p < 0.05 was regarded as
statistically significant.
A total of 244 subjects (192 patients and 52 controls)
were studied. Gender distribution were as follows: 83
male (41.2%) and 109 female (56.8%) patients and 25
male (48.1%) and 27 female (51.9%) controls. They
were aged 55.4 ± 11.3 yrs and 46.3 ± 11.9 yrs
respectively (p<0.001) with a range of 27 to 84 years.
99 patients (51.7%) had a co-existing hypertension.
Mean duration of illness was 7.6 ± 6.9 years. Control
of diabetes and / or hypertension was good in only
33.3% of the patients (37 out of 111 patients). 61.3%
had both poor control and dyslipidaemia. Some
clinical and biochemical characteristics (mean ± SD)
of the patients and control groups are shown in table 1
Mean values of lipid profiles were higher in the
patients than controls. LDL-C and HDL-C were
significantly higher and lower respectively. No
significant differences were observed for the others.
The patients also had significantly higher BMI than
the controls. Similar differences were also noted in
both the WC and WHR though it is to be noted that
gender-specific cut-off levels are recommended for
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Table 1
* - p value between patients and control subjects
. Clinical and biochemical characteristics (mean ± SD) of the
Subjects
Out of the 207 subjects with dyslipidaemia (i.e at
least one abnormal lipid profile), 171 (82.6%) were
patients while 36 (17.4%) = 12.5,
df = 1, p < 0.001). The prevalence of dyslipidaemia
among the patients was 89.1%. The mean values of
the lipid profiles were significantly higher among
the patients who had dyslipidaemia except for TG




Distribution of lipid profile among the
patients
Dyslipidaemia was noted with each of the TC,
LDL-C, HDL-C and TG as shown in figure 1.
Reduced HDL-C constituted the highest single
abnormality (59.4%) followed by elevated LDL-C
(58.9%), TC (55.2%) and TG (25.0%).
Abnormalities in the lipid profile ranged from
single to multiple abnormalities (fig 2). The two
patients who had abnormalities in all the lipid
profiles were both females.Obesity was common
among the patients with dyslipidaemia. 88.3% of
the patients with dyslipidaemia were obese
Table 2
Figure 2.
or overweight (using all the anthropometric indices
which include: WC, WHR and BMI). There was no
significant association between obesity and
dyslipidaemia ( [withYate's correction] = 0.349, df
=1, p = 0.56).
. Mean Lipid Profiles Of Patients With
And Without Dyslipidaemia (mean ± Sd) In
Mmol/.
Proportion of Single And Combined
Dyslipidaemia
Lipid No Dyslipidaemia Dyslipidaemia p value
Profile (n=21) (n=171)
(Mmo1/1)
TC 4.24±0.76 5.73±1.58 <0.001
HDL-C 1.41± 53 1 07± 445 0.01






















Age (yrs) 55.4±11.3 51.0±11.1 59.5± 9.9 46.3 ± 11.9 <0.001
Height (m) 1.64±0.09 1.65±0.09 1.64 ± 0.09 1.68 ± 0.09 < 0.05
Weight (kg) 77.6±14.6 77.0±15.0 78.1 ± 14.3 77.0 ± 13.0 >0.05
BMI (kg/m2) 28.7 ± 5.2 28.3 ± 5.3 29.1 ± 5.1 27.2 ± 3.8 < 0.05
Waist circumference (cm) 97.6±12.5 95.4±12.4 99.6 ± 12.2 91.8 ± 13.0 < 0.01
Hip circumference
(cm)
105.2±11.1 105.2±11.4 105.3 ± 10.9 103.7±13.7 >0.05
WHR 0.91 ±0.13 0.89 ± 0.11 0.93 ± 0.14 0.86 ± 0.17 < 0.05
Total cholesterol
(mmol/l)
5.57 ± 1.57 5.42 ± 1.27 5.70 ± 1.80 5.23±0.95 >0.05
LDL-C (mmol/l) 3.88 ± 1.45 3.83 ± 1.22 3.92 ± 1.64 3.48±0.94 < 0.05
HDL-C (mmol/l) 1.11 ± 0.47 1.12 ± 0.54 1.09 ± 0.39 1.25 ± 0.38 < 0.05
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No of abnormal lipid profiles
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104 (60.8%) were females, while 67 (39.2%) were
males. There was a significant associ between




= 10.4, df =1, p = 0.001)
The proportion of patients identified as being either
overweight or obese is as shown in table 3.
Table 3.
Males 41.0% 48.2% 27.7%
Females 80.0% 83.5% 42.2%
All the measures of obesity identified greater number
of female patients as being obese (table 3). Among
both gender, waist to hip ratio (WHR) identified the
highest (males = 48.2%; females = 83.5%) while
body mass index (BMI) identified the least (males =
27.7%; females = 42.2%) proportions of obese
patients.
The strengths and directions of association between
the various lipid profiles, and / or anthropometric
indices, which ranged from weak to strong, are
shown in the correlation matrix (table 4). Generally,
correlations were strong, positive, and significant
between variables that measured similar attributes.
For instance, LDL-C was strongly positive, and
significantly correlated with TC while it was very
Proportion of Patients Identified As
Obese or Overweight Using The Anthropometric
Indices of Obesity
WC(cm) WHR BM1(kg/m )
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weakly correlated with WC and WHR whereas the
value of correlation coefficient between BMI and WC
was also high and in the positive direction.
Dyslipidaemia was found to be highly prevalent
(82.6%) among the subjects who participated in this
study. This was relatively higher (89.1%) among the
patients. This is similar to the observation that was
made in South Africa where a prevalence of 90.3%
was reported. Our result appeared relatively higher
than 60.4% earlier reported in Nigeria by Agbola-
Abu et al ; a study that was done among subjects of
high socioeconomic class. Though we did not classify
our subjects based on socioeconomic class, our study
suggests an increasing prevalence of dyslipidaemia
considering the mixed nature of patients who attend
the tertiary health care facilities in Nigeria. This
difference also may be attributed to the underlying
disease process in our patients i.e diabetes and
hypertension. Diabetes mellitus has been associated
with abnormal lipid profiles and the presence of
diabetes either alone or in co-existence with
hypertension as in this study was significantly
associated with dyslipidaemia. This may not be
unrelated to insulin resistance which has been closely
associated with diabetes dyslipidaemia, and
hypertension. Increasing urbanization is another
factor that may explain the very high prevalence of








* p < 0.05; ** p < 0.01
Pearson's correlation coefficient (r) between the various anthropometric and biochemical
variables
TC LDL HDL TG WC HC BMI
LDL 0.832**
HDL 0.145* -0.026
TG 0.323** 0.120 0.123
WC 0.035 0.010 0.074 0.172*
HC 0.024 -0.003 0.029 0.090 0.757**
BMI -0.016 -0.040 0.075 0.065 0.713** 0.761**
WHR 0.054 0.046 0.049 0.130 0.323** -0.018 0.144*
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Increasing urbanization has been observed to be
associated with modernization of lifestyle which is
largely characterised by physical inactivity, change
in dietary pattern and consequently, development of
obesity. In the past few years, most of our urban
cities have witnessed an increase in the number of
fast food outlets as well as information technology
revolution; both of which have greatly influenced
our way of life. Several studies have previously
documented the lipid pattern in adult Nigerians
living in different urban centres. These generally
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showed low lipid values compared to Caucasian
values. Mean total cholesterol as observed among
the apparently healthy controls in our study (5.23 ±
0.95 mmol/L) was higher than that observed in
earlier studies in healthy Nigerians reported in
Lagos (3.54 ± 0.14 mmol/L) , Benin (4.82 ±
1.03mmol/L), and Port Harcourt (4.76 ± 1.06
mmol/L). There is paucity of studies on insulin
resistance among healthy Nigerians; therefore
whether insulin resistance which is associated with




unknown. Abnormalities of weight gain due to
excess fat (overweight / obesity)
determinants include female gender, urban dwelling
or socioeconomic class, glycaemic control and
ethnicity. The high prevalence of overweight /
obesity in this study showed that abnormalities of
weight are not only common among diabetic patients
but also among healthy Nigerians. This could add to
the other driving forces responsible for the
increasing prevalence of cardiovascular risk factors.
Central obesity has been shown to be the most
pathogenically important in the aetiology of
metabolic disorders. Measures of central obesity
(WHR and WC) identified greater proportion of
individuals with obesity compared to BMI which is a
measure of generalized obesity. This finding is
similar to the observation made by Bakari et al
among type 2 diabetic Hausa-Fulani Nigerians in
which BMI suggested that obesity is not common in
Nigerian diabetic patients when compared to waist to
hip ratio. There is the need to determine the cut-off
values of these indices of obesity in Nigerians in
conformity with prevailing ethnic and racial
differences that have been observed and highlighted
may explain the rise
in total cholesterol and other abnormalities. Our
patient and control subjects had high values of mean
BMI (28.7 vs 27.2 kg/m respectively); both in
keeping with overweight. This is similar to 28.76 ±
5.91 kg/m observed by Akpa et al in Port Harcourt
among healthy adults.
Age may also have accounted for some of the
differences observed in these studies. Though our
subjects had mean age that was within the middle age
group, they were older and younger than those
studied in Port Harcourt and Benin respectively.
Ageing can lead to increased sedentary living,
excessive food intake, and consequently obesity. It is
also associated with reduced cholesterol metabolism
and thus increased accumulation of lipids in the
body.
The commonest abnormality noted was low HDL-C
(59.4%) with TG being the least (25%). While a
lower prevalence of hypertriglyceridaemia was
equally reported among urban African Americans ,
these seemed to vary with the pattern of raised TG
which is one of the abnormalities that most
commonly characterizes diabetic dyslipidaemia.
The predominance of combined dyslipidaemia noted
in this study is comparable to other studies. It is an
indication of its metabolic basis and will affect its
management as different classes of drugs can be used
in its treatment depending on the predominant
abnormalities.Obesity is a known determinant of
abnormal lipid profile. High prevalence of obesity












in the 2005 definition of the metabolic syndrome by
the International Diabetes Federation (IDF). The
control of diabetes and hypertension was poor in our
study (61.3%). This is similar to the findings of Eid et
al. in which poor control of both morbidities was
present in over 70% of their study population.
Possible reasons for this include: poor health seeking
behaviours, low level of literacy, poverty, poor
compliance and adherence with follow up visits and
medications. Chronic disorders are also sometimes
viewed more from a spiritual point of view in Africa;
hence, the common practice of the use of alternative
medicines such as roots and herbs. This may
adversely affect interventional outcomes due to
unproven efficacy of these agents and their effect on
compliance with standard medications. Treatment of
patients should be individualized in other to enhance
compliance and adherence. Lifestyle modifications
which can be preventive and use of appropriate
pharmacological agents will yield better results.
In conclusion, this study has shown that the
prevalence of dyslipidaemia is high among type 2
diabetic patients in Nigeria and that it is associated
with high prevalence of obesity and combined
dyslipidaemia. These factors will no doubt
predispose them to increased cardiovascular
morbidity and mortality especially in the presence of
small dense LDL particles. Intensive effort at
lowering abnormal lipid profiles therefore should be
focused on; employing both non-pharmacological
and pharmacological means. A review of the current
status of non-communicable diseases in Nigeria is
therefore necessary.
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